Nabriva Therapeutics plc (NBRVF) has a market capitalization of $646.00 and trades at $0.00. The 52-week range is 0.0001-0.0002.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-21.32, annual revenue of $35.67M.
The stock has a beta of 5.32, operates in the Healthcare sector.
